Pictured: Human cell nucleus
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, April 8, 2014

The discovery of a molecular process that slows down cell division could provide new understanding about how some cancers develop.

Pictured: Douglas Levine
Finding
By Jim Stallard, MA, Writer/Editor  |  Tuesday, April 1, 2014

Researchers have identified a genetic mutation that appears to cause a rare but very aggressive type of ovarian cancer in young women.

Pictured: Jan Grimm
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Monday, March 10, 2014

Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.

 Pictured: Cancer cell on blood vessel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, February 27, 2014

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.

Pictured: Nai-Kong Cheung & Jeremy D
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, January 9, 2014

Common genetic alterations in neuroblastoma tumors may help doctors predict the likelihood the cancer will spread to the brain.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 12, 2013

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Ross Levine
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Pictured: Casper zebrafish
Snapshot
By Jennifer Bell, PhD  |  Tuesday, December 3, 2013

Physician and cell biologist Richard White has generated a transparent and stripeless strain of zebrafish to study how tumors develop the capacity to metastasize to new organs.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 13, 2013

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Pictured: Sarat Chandarlapaty
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, November 8, 2013

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 24, 2013

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.

Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 15, 2013

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Breast cancer mosaic
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, October 9, 2013

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

Pictured: Pseudomonas aeruginosa
Snapshot
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 1, 2013

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

Pictured: Daniel Thorek & Jan Grimm
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, September 25, 2013

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

Center News

Stay Informed

Get the latest information about cancer care and research every month.